BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 21920697)

  • 1. Achieving quality indicator benchmarks and potential impact on coronary heart disease mortality.
    Wijeysundera HC; Mitsakakis N; Witteman W; Paulden M; van der Velde G; Tu JV; Lee DS; Goodman SG; Petrella R; O'Flaherty M; Capewell S; Krahn M
    Can J Cardiol; 2011; 27(6):756-62. PubMed ID: 21920697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The population mortality benefits of maximizing the number of eligible patients receiving appropriate cardiology treatments in Ireland.
    Kabir Z; Bennett K; Shelley E; Unal B; Critchley J; Feely J; Capewell S
    QJM; 2006 Aug; 99(8):523-30. PubMed ID: 16861717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics and baseline clinical predictors of future fatal versus nonfatal coronary heart disease events in older adults: the Cardiovascular Health Study.
    Pearte CA; Furberg CD; O'Meara ES; Psaty BM; Kuller L; Powe NR; Manolio T
    Circulation; 2006 May; 113(18):2177-85. PubMed ID: 16651468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of acute beta-blocker therapy for patients with non-ST-segment elevation myocardial infarction.
    Miller CD; Roe MT; Mulgund J; Hoekstra JW; Santos R; Pollack CV; Ohman EM; Gibler WB; Peterson ED
    Am J Med; 2007 Aug; 120(8):685-92. PubMed ID: 17679127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic analysis of treatments reducing coronary heart disease mortality in England and Wales, 2000-2010.
    Fidan D; Unal B; Critchley J; Capewell S
    QJM; 2007 May; 100(5):277-89. PubMed ID: 17449875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decline of coronary heart disease mortality in The Netherlands from 1978 to 1985: contribution of medical care and changes over time in presence of major cardiovascular risk factors.
    Bots ML; Grobbee DE
    J Cardiovasc Risk; 1996 Jun; 3(3):271-6. PubMed ID: 8863098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apparently coronary heart disease-free patients in the coronary care unit: characteristics, medical care, and 1-year outcome.
    Brodin EC; Shahar E; Rosamond WD; McGovern PG; Sprafka JM; Doliszny KM; Luepker RV
    Coron Artery Dis; 1994 Sep; 5(9):737-43. PubMed ID: 7858763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent trends in acute coronary heart disease--mortality, morbidity, medical care, and risk factors. The Minnesota Heart Survey Investigators.
    McGovern PG; Pankow JS; Shahar E; Doliszny KM; Folsom AR; Blackburn H; Luepker RV
    N Engl J Med; 1996 Apr; 334(14):884-90. PubMed ID: 8596571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome.
    Yan AT; Yan RT; Tan M; Huynh T; Soghrati K; Brunner LJ; DeYoung P; Fitchett DH; Langer A; Goodman SG;
    Am Heart J; 2007 Dec; 154(6):1108-15. PubMed ID: 18035083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCORT/CCS quality indicators for acute myocardial infarction care.
    Tran CT; Lee DS; Flintoft VF; Higginson L; Grant FC; Tu JV; Cox J; Holder D; Jackevicius C; Pilote L; Tanser P; Thompson C; Tsoi E; Warnica W; Wielgosz A; ;
    Can J Cardiol; 2003 Jan; 19(1):38-45. PubMed ID: 12571693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Explaining the increase in coronary heart disease mortality in Beijing between 1984 and 1999.
    Critchley J; Liu J; Zhao D; Wei W; Capewell S
    Circulation; 2004 Sep; 110(10):1236-44. PubMed ID: 15337690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
    Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
    Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
    Whitfield MD; Gillett M; Holmes M; Ogden E
    Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benchmarking the vital risk of waiting for coronary artery bypass surgery in Ontario.
    Naylor CD; Szalai JP; Katic M
    CMAJ; 2000 Mar; 162(6):775-9. PubMed ID: 10750462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Coronary heart disease risk factors in Croatia and worldwide: results of the Interheart study].
    Carević V; Rumboldt M; Rumboldt Z;
    Acta Med Croatica; 2007 Jun; 61(3):299-306. PubMed ID: 17629106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disability predicted mortality in men but not women with coronary heart disease.
    Kattainen A; Reunanen A; Koskinen S; Martelin T; Knekt P; Aromaa A
    J Clin Epidemiol; 2004 May; 57(5):513-21. PubMed ID: 15196622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender differences in time to presentation for myocardial infarction before and after a national women's cardiovascular awareness campaign: a temporal analysis from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress ADverse Outcomes with Early Implementation (CRUSADE) and the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network-Get with the Guidelines (NCDR ACTION Registry-GWTG).
    Diercks DB; Owen KP; Kontos MC; Blomkalns A; Chen AY; Miller C; Wiviott S; Peterson ED
    Am Heart J; 2010 Jul; 160(1):80-87.e3. PubMed ID: 20598976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study.
    Maradit-Kremers H; Crowson CS; Nicola PJ; Ballman KV; Roger VL; Jacobsen SJ; Gabriel SE
    Arthritis Rheum; 2005 Feb; 52(2):402-11. PubMed ID: 15693010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical characteristics, in-hospital outcomes and predictors of in-hospital mortality in patients with acute coronary syndromes without persistent ST-segment elevation assigned to early invasive treatment strategy].
    Szyguła-Jurkiewicz B; Wojnicz R; Trzeciak P; Niklewski T; Zembala M; Poloński L
    Przegl Lek; 2005; 62(5):265-9. PubMed ID: 16334529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of an initial strategy of medical therapy without percutaneous coronary intervention in high-risk patients from the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial.
    Maron DJ; Spertus JA; Mancini GB; Hartigan PM; Sedlis SP; Bates ER; Kostuk WJ; Dada M; Berman DS; Shaw LJ; Chaitman BR; Teo KK; O'Rourke RA; Weintraub WS; Boden WE;
    Am J Cardiol; 2009 Oct; 104(8):1055-62. PubMed ID: 19801024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.